SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-254653
Filing Date
2017-08-10
Accepted
2017-08-10 17:21:22
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d431861ds3.htm S-3 359300
2 EX-1.2 d431861dex12.htm EX-1.2 157147
3 EX-4.2 d431861dex42.htm EX-4.2 268679
4 EX-4.3 d431861dex43.htm EX-4.3 259786
5 EX-5.1 d431861dex51.htm EX-5.1 19363
6 EX-12.1 d431861dex121.htm EX-12.1 20698
7 EX-23.1 d431861dex231.htm EX-23.1 1284
8 GRAPHIC g431861g76a11.jpg GRAPHIC 49732
  Complete submission text file 0001193125-17-254653.txt   1155905
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-219890 | Film No.: 171022326
SIC: 2836 Biological Products, (No Diagnostic Substances)